| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd6a5641409ede9e506b00e6b0950141 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 |
| filingDate |
1992-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1994-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39d9f1bb900e2e19a530e020bde28932
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8711fcb46f607b3b8895d627abf2c7a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30daaab0e591fbd4175705a108f87a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e625d7f3c764287e761f2813568a7d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdb86ff81cab4d74b00daf9dc988ee65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15402c6200c8e0df55f8e0e89dd613f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d347dd7d19e9af49aedd72a10e8a64d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd0f189918bf228591d02d438ecd518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b589420331f9987a37061968ea6b788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d421f8c1165d1e3f428f16a38131904d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65ffd2d244633edcf8d4e59b858d425e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aafe977ee10f116a16b3f2d93810e82a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3feaa35343bf2c7bcee3e4eaa231427 |
| publicationDate |
1994-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2020933-C1 |
| titleOfInvention |
Drug stimulating reparative regeneration of tissues |
| abstract |
FIELD: medicine. SUBSTANCE: quaternary ammoniacal salt of conidine (oligomer-25), heparin antagonist, is used for stimulating reparative regeneration of injured tissues. It has been found that single administration of this drug in dose of 2 to 4 mg/kg of animal body mass accelerates recovery of liver after acute toxic affection by CCl 4 . Wound cover resulting from introducing disclosed stimulator into collagen stimulates adhesion of full-layer incised wounds. Adhesion acceleration index of disclosed drug accounts for 100 % as compared to 36 % of collagen sponge "Combutec" and 20 % of "Meturacol" sponge. EFFECT: more effective medicinal preparation. 4 tbl |
| priorityDate |
1992-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |